Shenzhen Neptunus Bioengineering Co., Ltd. (SHE:000078)

SHE:000078 Revenue

Shenzhen Neptunus Bioengineering had revenue of 5.35B CNY in the quarter ending June 30, 2026, a decrease of -22.81%. This brings the company's total for the last twelve months to 23.66B, down -15.51% year-over-year. In the year 2025, Shenzhen Neptunus Bioengineering had annual revenue of 26.67B, down -12.04%. That makes Shenzhen Neptunus Bioengineering the 3,361st largest company in the world by revenue and 399th in China.

• Revenue (ttm): 23.66B
• Revenue Growth: -15.51%
• P/S Ratio: 0.15
• Revenue / Employee: 3.51M
• Employees: 6,734
• Market Cap: 3.50B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceutical Distribution 16.49B 61.8%
• Medical Instruments 9.56B 35.8%
• Pharmaceutical Manufacturing 429.71M 1.6%
• Health Products, Food 141.70M 0.5%
• Unallocated Other 55.39M 0.2%

Fiscal year ended Dec 31, 2025 See the full SHE:000078 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	26.67B	-3.65B	-12.04%
Dec 31, 2024	30.32B	-6.10B	-16.75%
Dec 31, 2023	36.42B	-1.42B	-3.74%
Jan 1, 2023	37.83B	-3.22B	-7.84%
Jan 1, 2022	41.05B	1.03B	2.58%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error